MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families

I.A. Meijer, L.J. Azcona, H. Darvish, C. Paisán-Ruiz (New York, NY, USA)

Meeting: 2016 International Congress

Abstract Number: 598

Keywords: Glutamate, Tremors: Clinical features, Tremors: Genetics

Session Information

Date: Tuesday, June 21, 2016

Session Title: Genetics (NON-PD)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To determine the prevalence of SLC6A17 mutations in a cohort of Iranian patients with intellectual disability and movement disorders.

Background: Mutations in the SLC6A17 gene were recently shown to cause a syndrome characterized by moderate to severe intellectual disability, progressive upper limb tremor, mild facial dysmorphisms, speech impairment and behavioral disturbances. Two mutations, c.484G>A, p.Gly162Arg and c.1898 C>G, p. Pro633Arg, were identified in a Dutch and Iranian consanguineous family respectively. The SLC6A17 gene encodes a protein predominantly expressed in the nervous system and thought to be involved in vesicular transport of specific amino acids and glutamate in glutamatergic synapses.

Methods: Twenty-three consanguineous Iranian families presenting with intellectual disability and movement disorders were identified. All SLC6A17 coding exons and 50bp of flanking sequence were amplified by PCR in all probands. Genomic primers for PCR amplifications and sequencing were designed using the public website ExonPrimer. PCR products were purified with ExoSAP-IT (Affymetrix), sequenced with Applied Biosystem BigDye Terminator v3.1 sequencing chemistry as per the manufacturer’s instructions, and analyzed using Sequencher 5.2 software.

Results: We did not identify a mutation in the SLC6A17 gene in our cohort. Interestingly, certain families did display homozygosity for known SNPs in the sequenced region.

Conclusions: We report that mutations in the SLC6A17 gene are not a common cause of autosomal-recessive intellectual disability with associated movement disorders in a large cohort of consanguineous Iranian families. Further genetic studies are underway to identify novel causes of intellectual disability and movement disorders in our cohort.

To cite this abstract in AMA style:

I.A. Meijer, L.J. Azcona, H. Darvish, C. Paisán-Ruiz. SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/slc6a17-mutations-are-not-a-common-cause-of-intellectual-disability-and-movement-disorders-in-a-large-cohort-of-consanguineous-iranian-families/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/slc6a17-mutations-are-not-a-common-cause-of-intellectual-disability-and-movement-disorders-in-a-large-cohort-of-consanguineous-iranian-families/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley